Publications

• October 24, 2016
  

  Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches

  Hanna D, Romero K, Schito M. Advancing Tuberculosis Drug Regimen Development through Innovative Quantitative Translational Pharmacology Methods and Approaches. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2016 Oct 24;56:208–11.

• October 1, 2016
  

  Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: A preliminary conceptual model and an evaluation of the adequacy of existing instruments

  Taylor F, Reasner DS, Carson RT, Deal LS, Foley C, Iovin R, Lundy JJ, Pompilus F, Shields AL, Silberg DG. Development of a symptom-based patient-reported outcome instrument for functional dyspepsia: a preliminary conceptual model and an evaluation of the adequacy of existing instruments. The Patient – Patient-Centered Outcomes Research 2016;9(5):409-418.

• October 1, 2016
  

  Development of a patient-reported outcome (PRO) instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase

  Gordon MF, Lenderking WR, Duhig A, Chandler J, Lundy JJ, Miller DS, et al. Development of a patient-reported outcome (PRO) instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: the qualitative research phase. 2015;12(1):75–84.

• October 1, 2016
  

  Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project

  Zignol M, Dean AS, Alikhanova N, Andres S, Cabibbe AM, Cirillo DM, Dadu A, Dreyer A, Driesen M, Gilpin C, Hasan R, Hasan Z, Hoffner S, Husain A, Hussain A, Ismail N, Kamal M, Mansjö M, Mvusi L, Niemann S, Omar SV, Qadeer E, Rigouts L, Ruesch-Gerdes S, Schito M, Seyfaddinova M, Skrahina A, Tahseen S, Wells WA, Mukadi YD, Kimerling M, Floyd K, Weyer K, Raviglione MC. Population-Based Resistance of Mycobacterium Tuberculosis Isolates to Pyrazinamide and Fluoroquinolones: Results from a Multicountry Surveillance Project. The Lancet Infectious Diseases. 2016 Oct;16(10):1185–92.

• September 29, 2016
  

  The International Neonatal Consortium: Collaborating to Advance Regulatory Science for Neonates

  Turner MA, Davis JM, McCune S, Bax R, Portman RJ, Hudson, LD. “The International Neonatal Consortium  Collaborating to Advance Regulatory Science for Neonates.” Pediatric Research 80(4): 462-463 (2016).